Huizhao Su

Papers

Total Citations

H-Index

About

Dr. Huizhao Su is a pioneering surgeon-researcher whose work centers on advancing minimally invasive techniques for hepatocellular carcinoma (HCC) treatment, with a particular focus on repeat liver resections. His most notable contribution involves the comparative evaluation of da Vinci robotic surgery versus traditional laparoscopy for managing recurrent HCC—a challenging clinical scenario where repeat operations carry heightened risks. In his landmark 2022 study, Dr. Su provided critical evidence demonstrating the safety and efficacy of robotic-assisted repeat hepatectomy, offering patients a less invasive option with potentially superior outcomes. This work, which has garnered 3 citations, addresses a significant gap in the literature, as few studies had previously examined robotic applications in repeat HCC surgery. By systematically analyzing perioperative outcomes, Dr. Su has helped establish a foundation for broader adoption of robotic platforms in complex hepatobiliary procedures. His research directly impacts surgical decision-making, empowering clinicians to offer tailored, advanced interventions for patients facing recurrent liver cancer. Dr. Su’s dedication to refining surgical techniques through rigorous comparative studies positions him as a key contributor to the evolution of oncologic liver surgery.